Key result
End-expiration inferior vena cava diameter was associated with an increased risk of poorly controlled hypertension among hemodialysis patients, where hypertension was prevalent in 82%.
Why the study?
What is the prevalence of interdialytic ambulatory hypertension and its association with volume excess in hemodialysis patients?
Cohort (n=369)
What is the prevalence of interdialytic ambulatory hypertension and its association with volume excess in hemodialysis patients?
Interdialytic hypertension is highly prevalent and poorly controlled in hemodialysis patients, with volume excess (indicated by IVC diameter) being a significant contributing factor.
Answers are grounded in this paper and cite their sources.
Interdialytic ABPM shows high hypertension prevalence in HD; leaves open optimal volume-targeted management strategies.
BACKGROUND: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP). METHODS: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated. RESULTS: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs. CONCLUSIONS: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.
No takes yet. Share an insight, caveat, or question.
Rajiv Agarwal (2011) conducted a cohort in Hemodialysis (n=369). End-expiration inferior vena cava (IVC) diameter was evaluated on Prevalence and control of hypertension. End-expiration inferior vena cava diameter was associated with an increased risk of poorly controlled hypertension among hemodialysis patients, where hypertension was prevalent in 82%.
Synapse has enriched 10 related papers. Consider them for comparative context: